Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MeiraGTx Holdings plc(MGTX) | 12,197,737 | 12,197,737 | 0 | $164.79M | $134.18M | 21.30% | -$30.62M |
| Inhibrx Biosciences, Inc.(INBX) | 1,157,926 | 1,157,926 | 0 | $109.71M | $115.89M | 18.40% | +$6.17M |
| Novavax, Inc.(NVAX) | 6,880,481 | 6,880,481 | 0 | $64.81M | $74.38M | 11.81% | +$9.56M |
| Korsana Biosciences | 0 | 1,994,011 | +1,994,011 | $0 | $63.81M | 10.13% | +$63.81M |
| Odyssey Therapeutics Inc. | 1,991,918 | 1,990,200 | -1,718 | $37.27M | $44.22M | 7.02% | +$6.95M |
| AnaptysBio | 821,917 | 821,917 | 0 | $55.48M | $41.31M | 6.56% | -$14.17M |
| Agomab Therapeutics NVADS | 2,783,096 | 2,783,096 | 0 | $36.12M | $30.89M | 4.90% | -$5.23M |
| First Tracks Biotherapeutics Inc. | 821,917 | 821,917 | 0 | $16.54M | $29.13M | 4.62% | +$12.59M |
| Electra Therapeutics Inc | 0 | 2,461,948 | +2,461,948 | $0 | $27.70M | 4.40% | +$27.70M |
| Attovia Therapeutics Inc | 0 | 1,082,855 | +1,082,855 | $0 | $18.56M | 2.95% | +$18.56M |
| Latigo Biotherapeutics Inc | 0 | 672,778 | +672,778 | $0 | $11.24M | 1.78% | +$11.24M |
| Immuneering CorpCL A | 2,708,559 | 2,708,559 | 0 | $13.52M | $11.09M | 1.76% | -$2.42M |
| MapLight Therapeutics Inc. | 912,041 | 912,041 | 0 | $32.69M | $9.29M | 1.48% | -$23.39M |
| Scribe Therapeutics | 0 | 500,000 | +500,000 | $0 | $9.20M | 1.46% | +$9.20M |
| Sab Biotherapeutics Inc | 0 | 2,198,500 | +2,198,500 | $0 | $6.97M | 1.11% | +$6.97M |
| Q32 Bio Inc. | 244,083 | 244,083 | 0 | $3.11M | $2.02M | 0.32% | -$1.09M |